Empirical treatment with pantoprazole as a diagnostic tool for symptomatic adult laryngopharyngeal reflux

Journal of Laryngology and Otology

Volumn 125, Issue 5, 2011, Pages 502-508

  Masaany, M ^a   Marina, M B ^b   Sharifa Ezat, W P ^b   Sani, A ^b  

^a HOSPITAL SULTANAH BAHIYAH   (Malaysia)

^b UNIVERSITI KEBANGSAAN MALAYSIA MEDICAL CENTER   (Malaysia)

Author keywords

Laryngitis; Laryngopharyngeal Reflux; Proton Pump Inhibitors; Therapeutics

Indexed keywords

PANTOPRAZOLE;

ADULT; ADULT DISEASE; AMBULATORY MONITORING; ARTICLE; BODY MASS; CLINICAL ARTICLE; CLINICAL ASSESSMENT TOOL; CLINICAL TRIAL; CORRELATION ANALYSIS; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG THERAPY; EMPIRICAL TREATMENT; EMPIRICISM; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HUMAN; LARYNGOPHARYNGEAL REFLUX; LARYNGOSCOPY; MALE; OUTCOME ASSESSMENT; PH MEASUREMENT; PREDICTIVE VALUE; PROTON PUMP INHIBITOR TEST; REFLUX FINDING SCORE; REFLUX SYMPTOM INDEX; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; TREATMENT DURATION; TREATMENT RESPONSE;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADOLESCENT; ADULT; BODY MASS INDEX; DOUBLE-BLIND METHOD; ENDOSCOPY, GASTROINTESTINAL; ESOPHAGEAL PH MONITORING; HUMANS; HYDROGEN-ION CONCENTRATION; MALAYSIA; MIDDLE AGED; PAIN; PAIN MEASUREMENT; PROSPECTIVE STUDIES; PROTON PUMP INHIBITORS; REGURGITATION, GASTRIC; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79956033906     PISSN: 00222151     EISSN: 17485460     Source Type: Journal    
DOI: 10.1017/S0022215111000120     Document Type: Article

References (28)

1. Koufman JA. The otolaryngologic manifestations of gastroesophageal reflux disease (GERD): a clinical investigation of 225 patients using ambulatory 24-hour pH monitoring and an experimental investigation of the role of acid and pepsin in the development of laryngeal injury. Laryngoscope 1991;101(4 Pt 2 Suppl 53):1-78
2. Carrau RL, Khidr A, Crawley JA, Hillson EM, Davis JK, Pashos CL. The impact of laryngopharyngeal reflux on patient-reported quality of life. Laryngoscope 2004;114:670-4 (Pubitemid 38548778)
3. Fraser AG. Gastroesophageal reflux and laryngeal symptoms. Aliment Pharmacol Ther 1994;8:265-72
4. Belafsky PC, Postma GN, Koufman JA. Validity and reliability of the reflux symptom index (RSI). J Voice 2002;16:274-7 (Pubitemid 36626833)
5. Qadeer MA, Swoger J, Milstein C, Hicks DM, Ponsky J, Richter JE et al. Correlation between symptom and laryngeal signs in laryngopharyngeal reflux. Laryngoscope 2005;115:1947-52 (Pubitemid 44391654)
6. Belafsky PC, Postma GN, Koufman JA. The validity and reliability of the reflux finding score (RFS). Laryngoscope 2001;111:1313-17 (Pubitemid 32730172)
7. Hickson C, Simpson CB, Falcon R. Laryngeal pseudosulcus as a predictor of laryngopharyngeal reflux. Laryngoscope 2001;111: 1742-5 (Pubitemid 32946446)
8. Dobhan R, Castell DO. Normal and abnormal proximal esophageal acid exposure: results of ambulatory dual-probe pH monitoring. Am J Gastroenterol 1993;88:25-9 (Pubitemid 23017937)
9. Panetti M, Pearson JP, Dettmar PW, Koufman JA. Active pepsin in airway secretions: possible evidence for new supraesophageal pH criteria. Gut 2001;120:A118-A119
10. Locke GR 3rd, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ 3rd. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmstead County, Minnesota. Gastroenterology 1997;112:1448-56 (Pubitemid 27181367)
11. Metz DC, Childs ML, Ruiz C, Weinstein GS. Pilot study of the oral omeprazole test for reflux laryngitis. Otolaryngol Head Neck Surg 1997;116:41-6 (Pubitemid 27066553)
12. Habermann W, Kiesler K, Eherer A, Friedrich G. Short-term therapeutic trial of proton pump inhibitors in suspected extraesophageal reflux. J Voice 2002;16:425-32 (Pubitemid 36628783)
13. Belafsky PC, Rees CJ. Identifying and managing laryngopharyngeal reflux. Hosp Physician 2007;27:15-20
14. S Brett. Science review: the use of proton pump inhibitors for gastric acid suppression in critical illness. Crit Care 2005;9: 45-50 (Pubitemid 40246770)
15. Goh KL, Benamouzig R, Sander P, Schwan T. Efficacy of pantoprazole 20 mg daily compared with esomeprazole 20 mg daily in the maintenance of healed gastroesophageal reflux disease: a randomized, double-blind comparative trial - the EMANCIPATE study. Eur J Gastroenterol Hepatol 2007;19: 205-11
16. Ho K, Spence J, Murphy MF. Review of pain-measurement tools. Ann Emerg Med 1996;27:427-32 (Pubitemid 26103799)
17. Lam P, Wei WI, Hui Y, How K. Prevalence of pH-documented laryngopharyngeal reflux in Chinese patients with clinically suspected reflux laryngitis. Am J Otolaryngol 2006;27:186-9
18. Koufman JA, Amin MR, Panetti M. Prevalence of reflux in 113 consecutive patients with laryngeal and voice disorders. Otolaryngol Head Neck Surg 2000;123:385-8
19. Pan GZ, Xu GM, Ke MY, Han SM, Guo HP, Li ZS et al. Epidemiological study of symptomatic gastroesophageal reflux disease in China: Beijing and Shanghai. Chinese Journal of Digestive Diseases 2000;1:2-8
20. Goh KL, Chang CS, Fock KM, Ke M, Park HJ, Lam SK. Gastro-oesophageal reflux disease in Asia. J Gastroenterol Hepatol 2000;15:230-8 (Pubitemid 30190734)
21. Shaker R, Castell DO, Schoenfeld PS, Spechler SJ. Nighttime heartburn is an under-appreciated clinical problem that impacts sleep and daytime function: the results of a Gallup survey conducted on behalf of the American Gastroenterological Association. Am J Gastroenterol. 2003;98:1487-93 (Pubitemid 36875337)
22. Ho KY, Lee HJ, Wong WY. Curry promotes significant acid reflux in patients with gastroesophageal reflux disease. J Gastroenterol Hepatol 2001;16(Suppl):A112
23. Gasiorowska A, Fass R. The proton pump inhibitor (PPI) test in GERD: does it still have a role? J Clin Gastroenterol 2008;42: 867-74
24. Lind T, Havelund T, Carlsson R, Anker-Hansen O, Glise H, Hernqvist H et al. Heartburn without esophagitis: efficacy of omeprazole therapy and features determining therapeutic response. Scand J Gastroenterol 1997;32:974-9 (Pubitemid 27433659)
25. Park W, Hicks DM, Khandala F, Richter JE, Abelson TI, Milstein C et al. Laryngopharyngeal reflux: prospective cohort study evaluating optimal dose of proton-pump inhibitor therapy and pretherapy predictors of response. Laryngoscope 2005;115:1230-8 (Pubitemid 40962361)
26. Belafsky PC, Postma GN, Koufman JA. Laryngopharyngeal reflux symptoms improve before changes in physical findings. Laryngoscope 2001;111:979-81 (Pubitemid 32523703)
27. Ruhl CE, Everhart JE. Overweight, but not high dietary fat intake, increases risk of gastroesophageal reflux disease hospitalization: the NHANES I epidemiologic follow-up study. First National Health and Nutrition Examination Survey. Ann Epidemiol 1999;9:424-5
28. Halum SL, Postma GN, Johnston C, Belafsky PC, Koufman JA. Patients with isolated laryngopharyngeal reflux are not obese. Laryngoscope 2005;115:1042-5 (Pubitemid 40776998)